<DOC>
	<DOCNO>NCT02752126</DOCNO>
	<brief_summary>A randomized phase II study palliative radiation advance central lung tumor intentional avoidance esophagus . Patients randomized standard care palliative thoracic radiation esophageal-sparing intensity-modulated radiation therapy ( ES-IMRT ) 1:1 ratio . Radiotherapy administer soon possible follow randomization subject follow 1 year completion radiation therapy . The primary endpoint esophageal quality life measure Esophageal Cancer Subscore ( ECS ) Functional Assessment Cancer Therapy-Esophagus ( FACT-E ) .</brief_summary>
	<brief_title>A Randomized Phase III Study Palliative Radiation Advanced Central Tumors With Intentional Avoidance Esophagus</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<criteria>American Joint Committee Cancer ( AJCC ) 7th edition stage IV NSCLC stage III eligible curative intent treatment Intended receive palliative radiotherapy thorax , dose 30Gy 10 fraction 20Gy 5 fraction . In either treatment arm least 5cm esophagus intend treatment field . Willingness ability provide inform consent Eastern Cooperative Oncology Group ( ECOG ) performance status 03 Age 18 year old Prior plan systemic therapy ( chemotherapy , immunotherapy , target agent ) permissible discretion treat medical oncologist , provide systemic treatment give within 2 week prior RT , concurrent RT within 2week period post RT . Concurrent palliative RT metastatic site permissible Life expectancy &gt; 3 month Prior thoracic RT Serious medical comorbidities preclude RT Pregnant lactate woman Inability attend full course RT plan followup visit Planned concurrent palliative RT stomach and/or liver Congenital abnormality esophagus severe disorder esophagus ( e.g . achalasia )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Esophageal spar</keyword>
	<keyword>Conventional radiotherapy</keyword>
	<keyword>Palliative radiation</keyword>
	<keyword>Central lung tumor</keyword>
</DOC>